TrialThe New England journal of medicine2015
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma.
Jia Ruan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
118 papers cite itlatest 60 shown
this paperpooled ittrialcites it